Ascendis Pharma A/S Revenue From Rendering Of Services
Ascendis Pharma A/S (ASND) reported Revenue From Rendering Of Services of EUR 11.79 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-02-12.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromRenderingOfServices · last filed 2025-02-12
- Ascendis Pharma A/S revenue from rendering of services for the quarter ending 2024-12-31 was 2.16M EUR, a 76.49% decline year-over-year.
- Ascendis Pharma A/S revenue from rendering of services for the quarter ending 2024-09-30 was 1.27M EUR, a 217.21% increase year-over-year.
- Ascendis Pharma A/S revenue from rendering of services for the quarter ending 2024-06-30 was 3.74M EUR, a 65.72% decline year-over-year.
- Ascendis Pharma A/S revenue from rendering of services for the quarter ending 2024-03-31 was 4.62M EUR, a 295.21% increase year-over-year.
| Period end | Revenue From Rendering Of Services 3 month | Revenue From Rendering Of Services 6 month | Revenue From Rendering Of Services 9 month | Revenue From Rendering Of Services 12 month |
|---|---|---|---|---|
| 2024-12-31 | 2.16M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 3.43M EUR derived: sum of 2 quarters · filed 2025-02-12 | 7.17M EUR derived: sum of 3 quarters · filed 2025-02-12 | 11.79M EUR 20-F · filed 2025-02-12 |
| 2024-09-30 | 1.27M EUR 6-K · filed 2024-11-14 | 5.01M EUR derived: sum of 2 quarters · filed 2024-11-14 | 9.64M EUR 6-K · filed 2024-11-14 | 18.82M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2024-06-30 | 3.74M EUR 6-K · filed 2024-09-03 | 8.36M EUR 6-K · filed 2024-09-03 | 17.54M EUR derived: sum of 3 quarters · filed 2025-02-12 | 17.94M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2024-03-31 | 4.62M EUR 6-K · filed 2024-05-02 | 13.80M EUR derived: sum of 2 quarters · filed 2025-02-12 | 14.20M EUR derived: sum of 3 quarters · filed 2025-02-12 | 25.11M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-12-31 | 9.18M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 9.58M EUR derived: sum of 2 quarters · filed 2025-02-12 | 20.49M EUR derived: sum of 3 quarters · filed 2025-02-12 | 21.66M EUR 20-F · filed 2025-02-12 |
| 2023-09-30 | 401.00K EUR 6-K · filed 2024-11-14 | 11.31M EUR derived: sum of 2 quarters · filed 2024-11-14 | 12.48M EUR 6-K · filed 2024-11-14 | 13.53M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | 10.91M EUR 6-K · filed 2024-09-03 | 12.08M EUR 6-K · filed 2024-09-03 | 13.13M EUR derived: sum of 3 quarters · filed 2025-02-12 | 15.53M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 1.17M EUR 6-K · filed 2024-05-02 | 2.22M EUR derived: sum of 2 quarters · filed 2025-02-12 | 4.62M EUR derived: sum of 3 quarters · filed 2025-02-12 | 5.23M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 1.05M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 3.45M EUR derived: sum of 2 quarters · filed 2025-02-12 | 4.06M EUR derived: sum of 3 quarters · filed 2025-02-12 | 4.43M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 2.40M EUR 6-K · filed 2023-11-07 | 3.01M EUR derived: sum of 2 quarters · filed 2023-11-07 | 3.38M EUR 6-K · filed 2023-11-07 | 3.54M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 612.00K EUR 6-K · filed 2023-09-05 | 983.00K EUR 6-K · filed 2023-09-05 | 1.14M EUR derived: sum of 3 quarters · filed 2024-02-07 | 1.34M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 372.00K EUR 6-K · filed 2023-04-27 | 524.00K EUR derived: sum of 2 quarters · filed 2024-02-07 | 727.00K EUR derived: sum of 3 quarters · filed 2024-02-07 | 953.00K EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | 152.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 355.00K EUR derived: sum of 2 quarters · filed 2024-02-07 | 581.00K EUR derived: sum of 3 quarters · filed 2024-02-07 | 751.00K EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 203.00K EUR 6-K · filed 2022-11-02 | 429.00K EUR derived: sum of 2 quarters · filed 2022-11-02 | 599.00K EUR 6-K · filed 2022-11-02 | 483.00K EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | 226.00K EUR 6-K · filed 2022-08-10 | 395.00K EUR 6-K · filed 2022-08-10 | 280.00K EUR derived: sum of 3 quarters · filed 2023-02-16 | 444.00K EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | 169.00K EUR 6-K · filed 2022-05-11 | 54.00K EUR derived: sum of 2 quarters · filed 2023-02-16 | 218.00K EUR derived: sum of 3 quarters · filed 2023-02-16 | 997.00K EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -115.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | 49.00K EUR derived: sum of 2 quarters · filed 2023-02-16 | 828.00K EUR derived: sum of 3 quarters · filed 2023-02-16 | 2.14M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | 164.00K EUR 6-K · filed 2021-11-10 | 943.00K EUR derived: sum of 2 quarters · filed 2021-11-10 | 2.25M EUR 6-K · filed 2021-11-10 | 3.30M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | 779.00K EUR 6-K · filed 2021-08-27 | 2.09M EUR 6-K · filed 2021-08-27 | 3.14M EUR derived: sum of 3 quarters · filed 2022-03-02 | 4.72M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | 1.31M EUR 6-K · filed 2021-05-27 | 2.36M EUR derived: sum of 2 quarters · filed 2022-03-02 | 3.94M EUR derived: sum of 3 quarters · filed 2022-03-02 | 5.82M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | 1.04M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | 2.63M EUR derived: sum of 2 quarters · filed 2022-03-02 | 4.50M EUR derived: sum of 3 quarters · filed 2022-03-02 | 9.92M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | 1.59M EUR 6-K · filed 2020-11-12 | 3.46M EUR derived: sum of 2 quarters · filed 2020-11-12 | 8.87M EUR 6-K · filed 2020-11-12 | 10.02M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | 1.87M EUR 6-K · filed 2020-08-27 | 7.29M EUR 6-K · filed 2020-08-27 | 8.44M EUR derived: sum of 3 quarters · filed 2021-03-10 | 8.46M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | 5.41M EUR 6-K · filed 2020-05-19 | 6.56M EUR derived: sum of 2 quarters · filed 2021-03-10 | 6.58M EUR derived: sum of 3 quarters · filed 2021-03-10 | 6.60M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | 1.15M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 1.17M EUR derived: sum of 2 quarters · filed 2021-03-10 | 1.19M EUR derived: sum of 3 quarters · filed 2021-03-10 | 1.22M EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | 20.00K EUR 6-K · filed 2019-11-18 | 38.00K EUR derived: sum of 2 quarters · filed 2019-11-18 | 66.00K EUR 6-K · filed 2019-11-18 | 346.00K EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | 18.00K EUR 6-K · filed 2019-08-28 | 46.00K EUR 6-K · filed 2019-08-28 | 326.00K EUR derived: sum of 3 quarters · filed 2020-04-03 | 760.00K EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | 28.00K EUR 6-K · filed 2019-05-30 | 308.00K EUR derived: sum of 2 quarters · filed 2020-04-03 | 742.00K EUR derived: sum of 3 quarters · filed 2020-04-03 | 1.19M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | 280.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | 714.00K EUR derived: sum of 2 quarters · filed 2020-04-03 | 1.16M EUR derived: sum of 3 quarters · filed 2020-04-03 | 1.53M EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | 434.00K EUR 6-K · filed 2018-11-28 | 878.00K EUR derived: sum of 2 quarters · filed 2018-11-28 | 1.25M EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | 444.00K EUR 6-K · filed 2018-08-29 | 816.00K EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | 372.00K EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | 1.63M EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | 3.19M EUR 20-F · filed 2018-03-28 |